Inflammatory bronchopulmonary response of preterm infants with microbial colonisation of the airways at birth

Archives of Disease in Childhood

Volumn 74, Issue 1, 1996, Pages

  Groneck, Peter ^a   Goetze Speer, Bettina ^b   Speer, Christian P ^b  

^a UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^b UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

Inflammatory response; Microbial colonisation; Preterm infants; Tracheobronchial aspirate

Indexed keywords

ALPHA 1 ANTITRYPSIN; ELASTASE; INTERLEUKIN 1; INTERLEUKIN 8; LEUKOTRIENE B4; MARKER;

ARTICLE; BACTERIAL COLONIZATION; CHEMOTAXIS; CONGENITAL DISORDER; CONTROLLED STUDY; HUMAN; INFLAMMATION OF THE LUNGS, BRONCHI AND PLEURA; LUNG LAVAGE; MAJOR CLINICAL STUDY; NEUTROPHIL; NEWBORN; NEWBORN INFECTION; PREMATURITY; PRIORITY JOURNAL; UREAPLASMA UREALYTICUM;

ALPHA 1-ANTITRYPSIN; BACTERIAL INFECTIONS; BIOLOGICAL MARKERS; BRONCHI; FEMALE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; INTERLEUKIN-1; INTERLEUKIN-8; LEUKOCYTE ELASTASE; LEUKOTRIENE B4; MALE; PANCREATIC ELASTASE; PROSPECTIVE STUDIES; TRACHEA; UREAPLASMA INFECTIONS; UREAPLASMA UREALYTICUM;

EID: 0030054182     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/fn.74.1.f51     Document Type: Article

References (33)

1. Webber S, Wilkinson D, Lindsell D, Hope PL, Dobson SRM, Isaacs D. Neonatal pneumonia. Arch Dis Child 1990; 65: 207-11.
2. Cassell GH, Waites KB, Crouse DT, et al. Association of Ureaplasma urealyticum infection in the lower respiratory-tract with chronic lung disease and death in very low birthweight infants. Lancet 1988; ii: 240-5.
3. Wang EE, Cassell GH, Sanchez PJ, Regan JA, Payne NR, Liu PP. Ureaplasma urealyticum and chronic lung disease: critical appraisal of the literature on causation. Clin Infect Dis 1993; 17 (suppl 1): S112-16.
4. Holtzman RB, Hageman JR, Yogev R. Role of Ureaplasma urcalyticum in bronchopulmonary dysplasia. J Pediatr 1989; 114: 1061-3.
5. Sherman MP, Goetzman BW, Ahifors CE, Wennberg RP. Tracheal aspiration and its clinical correlates in the diagnosis of congenital pneumonia. Pediatrics 1980; 65: 258-63.
6. Arnon S, Grigg J, Silverman M. Association between pulmonary and gastric inflammatory cells on the first day of life in preterm infants. Pediatr Pulmonol 1991; 16: 59-61.
7. Payrie NR, Steinberg SS, Ackerman P, Chrenka BA, Sane SM, Anderson KT, et al. New prospective studies of the association of Ureaplasma urealyticum colonization and chronic lung disease. Clin Infect Dis 1993; 17 (suppl 1): S117-21.
8. Grigg J, Arnon S, CKase A, Silverman M. Inflammatory cells in the lungs of premature infants on the first day of life: perinatal risk factors and origin of cells. Arch Dis Child 1993; 69: 40-3.
9. Grigg J, Barber A, Silverman M. Increased levels of bronchoalveolar fluid interleukin-6 in preterm ventilated infants after prolonged rupture of membranes. Am Rev Respir Dis 1992; 45: 782-6.
10. Fujimura M, Kitajima H, Nakayama M, Increased leucocyte elastase of the tracheal aspirate at birth and neonatal pulmonary emphysema. Pediatrics 1993; 92: 564-9.
11. Speer CP, Robertson B, Cursted T, Halliday H, Compagnone D, Gefeller O, et al. Randomized European multicenter trial of surfactant therapy for severe neonatal respiratory distress syndrome: single versus multiple doses of Curosurf. Pediatrics 1992; 89: 13-20.
12. Groneck P, Goetze-Speer B, Oppermann M, Eiffert H, Speer CP. Association of pulmonary inflammation and increased microvascular permeability during the development of bronchopulmonary dysplasia: a sequential analysis of inflammatory mediators in respiratory fluids of high risk preterm infants. Pediatrics 1994; 93: 712-18.
13. Groneck P, Reuss D, Goetze-Speer B, Speer CP. Effects of dexamethasone on chemotactic activity and inflammatory mediators in tracheobronchial aspirates of preterm infants at risk for chronic lung disease. J Pediatr 1993; 122: 938-44.
14. Watts CL, Fanaroff M, Bruce MC. Elevation of fibronectin levels in lung secretions of infants with respiratory distress syndrome and development of bronchopulmonary dysplasia. J Pediatrics 1992; 120: 614-20.
15. Dinarello CA. Cytokines: interleukin-1 and tumor necrosis factor. In: Gallin JI, Goldstein IM, Synderman R, eds. Inflammation, basic principles and clinical correlates. New York: Raven Press, 1988: 195-208.
16. Ulich TR, Watson LR, Yin S, Guo K, Wang P, Thang H, et al. The intratracheal administration of endotoxin and cytokines, I. Characterisation of LPS-induced IL-1 and TNF mRNA expression and the LPS-, IL-1-, and TNF induced inflammatory exsudate. Am J Pathol 1991; 138: 1485-96.
17. Ulich TR, Yin S, Guo K, delCastillo J, Eisenberg SP, Thompson RC. The intratracheal administration of endotoxin and cytokines. III. The interleukin-1 receptor antagonist inhibits endotoxin- and IL-1 induced acute inflammation. Am J Pathol 1991; 138: 521-4.
18. Standiford TJ, Arenberg DA, Danforth JM, Kunkel SL, Van Otteren GM, Stricter RM. Lipoteichoic acid induces secretion of interleukin-8 from human blood monocytes: a cellular and molecular analysis. Infect Immunol 1994; 62: 119-25.
19. Wilmott RW, Kassab JT, Kilian PL, Benjamin WR, Douglas SD, Wood RE. Increased levels of interleukin-1 in bronchoalveolar washings from children with bacterial pulmonary infections. Am Rev Respir Dis 1990; 142: 365-8.
20. Hopkins H, Stull T, von Essen SG, Robbins RA, Rennard SI. Neutrophil chemotactic factors in bacterial pneumonia. Chest 1989; 95: 1021-7.
21. Fick RB, Robbins RA, Squier SU, Schoderbek WE, Russ WD. Complement activation in cystic fibrosis respiratory fluids: in vivo and in vitro generation of C5a and chemotactic activity. Ped Res 1986; 20: 1258-68.
22. Massion PP, Inoue H, Richman-Eisenstad J, Grunberger D, Jorens PG, Housset B, et al. Novel Pseudomonas product stimulates interleukin-8 production in airway epithelial cells in vitro. J Clin Invest 1994; 93: 26-32.
23. Ozaki T, Hayashi H, Tani K, Ogushi F, Yasuoka S, Ogura T. Neutophil chemotactic factors in the respiratory tract of patients with chronic airway diseases of idiopathic pulmonary fibrosis. Am Rev Respir Dis 1992; 145: 85-91.
24. Rodriguez JL, Miller CG, DeForge LE, Kelty L, Shanley CJ, Bartlett RH, et al. Local production of interleukin-8 is associated with nosocomial pneumonia. J Trauma 1992; 33: 74-82.
25. Chollet-Martin S, Montravers P, Gilbert C, Elbim C, Desmonds JM, Fagon JY, et al. High levels of interleukin-8 in the blood and alveolar spaces of patients with pneumonia and adult respiratory distress syndrome. Infect Immunol 1993; 61: 4553-9.
26. Stancombe BB, Walsh WF, Derdak SD, Dixon P, Hensley D. Induction of human neonatal pulmonary fibroblast cytokines by hyperoxia and ureaplasma urealyticum. Clin Infect Dis 1993; 17 (suppl 1): S154-7.
27. De Silva NS, Quinn PA. Endogenous activity of phospholipases A and C in Ureaplasma urealyticum. J Clin Microbiol 1986; 23: 354-9.
28. De Forge LE, Preston AM, Takeuchi E, Kenney J, Boxer LA, Remick DG. Regulation of interleukin-8 gene expression by oxidant stress. J Biol Chem 1993; 268: 25568-76.
29. 1-proteinase inhibitor and lactoferrin concentrations in endotracheal aspirates of ventilated newborns. Pediatr Pulmonol 1992; 13: 90-4.
30. Abrams WR, Fein AM, Kucich U, Kueppers F, Yamada H, Kuzmowycz T, et al. Proteinase inhibitory function in inflammatory lung disease. Am Rev Respir Dis 1984; 129: 735-41.
31. Walti H, Tordet C, Gerbaut L, Saugier P, Moriette G, Relier JP. Persistent elastase/proteinase inhibitor imbalance during prolonged ventilation of infants with bronchopulmonary dysplasia: evidence for the role of nosocomial infections. Ped Res 1989; 26: 351-5.
32. Speer CP, Reuss D, Harms K, Herting E, Gefeller O. Neutrophil elastase and acute pulmonary damage in infants with severe respiratory distress syndrome. Pediatrics 1993; 91: 794-9.
33. Kotecha S, Chan B, Azam N, Silverman M, Shaw R. Increase in interleukin-8 and soluble intercellular adhesion molecule-1 in bronchoalveolar lavage fluid from premature infants who develop chronic lung disease. Arch Dis Child 1995; 72: F90-6.